CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 22 enrolled
Drug / intervention
Proton radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01600040
NCT01600040N/ACompleted

Pilot Study of Adjuvant Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix With Metastases to Regional Lymph Nodes

Massachusetts General Hospital·interventional·Posted May 16, 2012·Updated Oct 29, 2024

In Brief

A clinical study evaluating Proton radiation therapy for Uterine Cancer and Cervical Cancer. Completed, enrolled 22 participants across 1 site.

Detailed Summary

Proton beam radiation therapy is known to spare surrounding normal tissues from radiation. Proton beam radiation delivers less radiation beyond the area of the target tissues. This may reduce side effects that patients would normally experience with standard (photon) radiation therapy which tends to unavoidably include more normal tissue along with tumor target tissue. In this research study, the investigators are looking to determine if proton beam radiation is effective in controlling your cancer growth. The investigators are also looking to see if proton beam radiation can reduce side effects when compared to standard radiation treatment (photon radiation).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMay 16, 2012
Enrollment StartAug 1, 2013
Primary CompletionOct 19, 2022
Study CompletionAug 10, 2023
TodayJul 2, 2026
Enrollment to primary: 9.2 yearsPosted 14.1 years ago

Interventions

Proton radiation therapyradiation

5 days per week (Mon-Fri) for 5-6 weeks